Display options
Share it on

J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):354-8. doi: 10.1136/jnnp.2005.075119.

Additional causes for distal sensory polyneuropathy in diabetic patients.

Journal of neurology, neurosurgery, and psychiatry

K C Gorson, A H Ropper

Affiliations

  1. Department of Neurology, St. Elizabeth's Medical Center, 736 Cambridge Street, Boston, MA 02135, USA. [email protected]

PMID: 16484643 PMCID: PMC2077706 DOI: 10.1136/jnnp.2005.075119

Abstract

OBJECTIVE: To assess the frequency of additional causes of distal sensory polyneuropathy (DSP) in patients with diabetes mellitus (DM).

METHODS: Retrospective review of patients with DM and DSP during a 5 year period. A quantitative sensory score (QSS) was determined at the initial evaluation and extensive laboratory and EMG studies were performed. Patients with one or more potential causes for DSP were compared to those with DM alone.

RESULTS: Fifty five patients (53%) had potential additional causes for DSP. These included: neurotoxic medications (seven), alcohol abuse (six), and B12 deficiency and renal disease (four each). The most common laboratory abnormalities were: abnormally low levels of vitamin B6 (11) or B1 (10), monoclonal gammopathy (eight), and hypertriglyceridaemia (eight). Twenty six (25%) subjects had more than one additional cause. Nine (9%) had three or more demyelinating features on EMG. There was a trend toward a lower QSS score (p = 0.05) and reduced mean amplitude of the sensory potentials in those with additional causes. Those with additional causes more often had upper limb sensory symptoms (p = 0.001) and sensory findings (p = 0.003).

CONCLUSION: There was a high frequency of additional sources of DSP in patients with DM. These patients more often had sensory symptoms and findings in the hands. Tests that may be useful in the evaluation of DSP in diabetic patients include measures of vitamins B1, B6, B12, serum triglycerides, and immunofixation.

References

  1. Muscle Nerve. 2002 Aug;26(2):288-90 - PubMed
  2. Arch Neurol. 2001 May;58(5):761-8 - PubMed
  3. Brain. 1994 Dec;117 ( Pt 6):1385-93 - PubMed
  4. Muscle Nerve. 1997 Oct;20(10):1275-83 - PubMed
  5. Neurology. 1993 Apr;43(4):817-24 - PubMed
  6. Neurology. 2005 Jan 25;64(2):199-207 - PubMed
  7. Brain. 2004 Aug;127(Pt 8):1723-30 - PubMed
  8. Muscle Nerve Suppl. 1999;8:S225-9 - PubMed
  9. Ann Neurol. 2003 Jul;54(1):19-29 - PubMed
  10. Neurology. 1994 Nov;44(11):2185-6 - PubMed
  11. Neurology. 1996 Jul;47(1):10-7 - PubMed
  12. Muscle Nerve. 1989 Jun;12(6):435-51 - PubMed
  13. Neurology. 1991 Jun;41(6):799-807 - PubMed
  14. N Engl J Med. 2005 Jan 27;352(4):341-50 - PubMed
  15. Neurology. 2002 May 28;58(10):1471-5 - PubMed
  16. J Neurol Sci. 2000 Feb 15;173(2):129-39 - PubMed
  17. Diabetes Care. 1997 Jul;20(7):1183-97 - PubMed
  18. Med Klin (Munich). 1993 Aug 15;88(8):453-7 - PubMed
  19. Am Heart J. 2004 Sep;148(3):456-61 - PubMed
  20. Can J Clin Pharmacol. 2003 Winter;10(4):184-8 - PubMed
  21. N Engl J Med. 1998 May 28;338(22):1601-7 - PubMed
  22. Muscle Nerve. 1988 Jan;11(1):21-32 - PubMed
  23. J Peripher Nerv Syst. 2004 Sep;9(3):138-43 - PubMed
  24. Muscle Nerve. 2000 Feb;23(2):164-74 - PubMed
  25. J Neurol. 2002 May;249(5):569-75 - PubMed
  26. J Clin Neuromuscul Dis. 2001 Dec;3(2):47-52 - PubMed
  27. J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):274-83 - PubMed
  28. J Neurol Neurosurg Psychiatry. 2001 Aug;71(2):205-9 - PubMed
  29. Muscle Nerve. 1991 Sep;14(9):858-62 - PubMed
  30. J Neurol Neurosurg Psychiatry. 2003 Jun;74 Suppl 2:ii15-ii19 - PubMed
  31. Arch Neurol. 2002 May;59(5):758-65 - PubMed
  32. Diabetes Care. 1997 Dec;20(12):1896-9 - PubMed

MeSH terms

Publication Types